BBI - Brickell Biotech, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
4.0600
-0.0400 (-0.98%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close4.1000
Open4.1761
Bid4.1100 x 800
Ask4.1900 x 900
Day's Range4.0600 - 4.1940
52 Week Range4.0000 - 9.5900
Volume8,112
Avg. Volume90,840
Market Cap31.712M
Beta (3Y Monthly)-0.17
PE Ratio (TTM)N/A
EPS (TTM)-9.5460
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.80
Trade prices are not sourced from all markets
  • GlobeNewswire

    Brickell Biotech Completes Merger with Vical

    Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company, today announced the completion of its merger with Vical Incorporated (“Vical”), following approval by Vical’s stockholders.

  • We're sorry this is all we were able to find about this topic.